UBC's Blog

UBC is committed to sharing ideas & insights with the pharmaceutical & biotech industry to address the full product lifecycle & support the development & commercialization of safe & effective products.

 

Penguins
Haley Kaplowitz, Executive Director, Safety, Epidemiology, Registries, and Risk Management - March 03, 2017
Last week, I spoke at Arena’s Outsourcing in Clinical Trials event in San Francisco on the value of leveraging disease natural history data in orphan drug development. Throughout the presentation, I emphasized that a well-designed...
Rare Disease Day 2017
UBC - February 27, 2017
On February 28, rare-disease communities around the world come together to advocate for an increase in research focused on rare diseases. When it comes to clinical research for rare and orphan diseases, the relationship with the...
An effective REMS program improves patient access to medication.
Annette Stemhagen, DrPH, FISPE, Senior Vice President, Safety, Epidemiology, Registries & Risk Management - February 14, 2017
The EXL Risk Evaluation & Mitigation Strategy Summit, held at the end of January, was an opportunity for colleagues across the industry to discuss many topics related to REMS, including benefit-risk counseling between patients and...
Platform recruitment for clinical trials
Liz Allan, Senior Director, Patient and Physician Services - February 08, 2017
Competing studies can be a challenge when enrolling patients in clinical trials. But when those studies are conducted by one sponsor, the need to engage with a single patient population can quickly turn into an asset and huge savings...
Recruiting for Alzheimer's clinical trials
Lashell Robinson, Patient & Physician Services - January 24, 2017
In the United States alone, more than 5 million people over age 65 have been diagnosed with Alzheimer’s disease. Today there is still no cure, but there is hope. More than 79 compounds are in clinical development for Alzheimer’s and...

Pages